STOCK TITAN

Guardant Health to Host Investor Day on September 7, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Guardant Health, Inc. will be hosting an Investor Day on September 7, 2023, in New York City. The event will feature presentations by several members of the company's leadership team. Interested parties can access a live and archived webcast of the presentation on the company website.
Positive
  • None.
Negative
  • None.

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today announced the company will be hosting an Investor Day on September 7, 2023, in New York City, NY starting at 8:00 a.m. Eastern time / 5:00 a.m. Pacific Time. The event will feature presentations by several members of the company's leadership team.

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com. Due to limited capacity, in-person attendance is available by invitation only.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360® CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening. For more information, visit guardanthealth.com and follow the company on LinkedIn and Twitter.

Source: Guardant Health, Inc.

Investor Contact:

investors@guardanthealth.com

Media Contact:

press@guardanthealth.com

Source: Guardant Health, Inc.

Guardant Health is hosting its Investor Day on September 7, 2023.

The Investor Day will take place in New York City, NY.

Interested parties can access a live and archived webcast of the presentation on the 'Investors' section of the company website at www.guardanthealth.com.

In-person attendance is available by invitation only due to limited capacity.
Guardant Health Inc

NASDAQ:GH

GH Rankings

GH Latest News

GH Stock Data

Dental Laboratories
Manufacturing
Link
Health Services, Medical/Nursing Services, Manufacturing, Dental Laboratories

About GH

we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.